Grapefruit Juice Reduces the Oral Bioavailability of Fexofenadine But Not Desloratadine

Author： Banfield C.   Gupta S.   Marino M.   Lim J.   Affrime M.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.41, Iss.4, 2002-01, pp. : 311-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Avoid even normal consumption of grapefruit juice if potential interaction with oral cardiovascular drugs

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 9, 2005-09 ,pp. : 21-24

Adis International

Access to resources Recommend Favorite

The effect of grapefruit juice on drug disposition

By Hanley Michael J   Cancalon Paul   Widmer Wilbur W   Greenblatt David J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 3, 2011-03 ,pp. : 267-286

Informa Healthcare

Access to resources Recommend Favorite

The effects of grapefruit juice on the pharmacokinetics of erythromycin

By Kanazawa S.   Ohkubo T.   Sugawara K.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 11, 2001-01 ,pp. : 799-803

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Pharmacodynamics of Desloratadine, Fexofenadine and Levocetirizine: A Comparative Review

By Devillier Philippe   Roche Nicolas   Faisy Christophe  

Clinical Pharmacokinetics, Vol. 47, Iss. 4, 2008-01 ,pp. : 217-230

Adis International

Access to resources Recommend Favorite

Effect of Grapefruit Juice in Relation to Human Pharmacokinetic Study

By  

Current Clinical Pharmacology, Vol. 1, Iss. 2, 2006-05 ,pp. : 157-161

Bentham Science Publishers

Access to resources Recommend Favorite